Home/Filings/4/0000930413-08-000036
4//SEC Filing

ELITE PHARMACEUTICALS INC /DE/ 4

Accession 0000930413-08-000036

$ELTPCIK 0001053369operating

Filed

Jan 2, 7:00 PM ET

Accepted

Jan 3, 9:20 PM ET

Size

18.8 KB

Accession

0000930413-08-000036

Insider Transaction Report

Form 4
Period: 2007-12-31
BERK BERNARD
DirectorChief Exec. Officer & Chairman
Transactions
  • Award

    Options

    2003-06-03$2.01/sh+300,000$603,0001,425,000 total
    Exercise: $2.01From: 2003-06-02Exp: 2013-06-02Common Stock (300,000 underlying)
  • Award

    Options

    2006-11-13$3.00/sh+300,000$900,0001,425,000 total
    Exercise: $3.00Exp: 2016-11-13Common Stock (300,000 underlying)
  • Award

    Options

    2003-06-23$2.15/sh+225,000$483,7501,425,000 total
    Exercise: $2.15From: 2005-09-02Exp: 2013-06-22Common Stock (225,000 underlying)
  • Award

    Options

    2005-09-02$2.69/sh+200,000$538,0001,425,000 total
    Exercise: $2.69Exp: 2015-09-02Common Stock (200,000 underlying)
  • Purchase

    Common Stock

    2007-12-31$2.08/sh+2,500$5,200192,300 total
  • Award

    Options

    2005-09-02$2.69/sh+400,000$1,076,0001,425,000 total
    Exercise: $2.69Exp: 2015-09-02Common Stock (400,000 underlying)
Footnotes (4)
  • [F1]They vest upon the closing of an exclusive product license for the United States national market, the entire European Union market or the Japan market or product sale transaction of all of the Company's ownership rights in the United States (only once for each individual product) for the Company's first "Non-Generic Opioid Drug" as to 150,000 options and for the Company's second "Non-Generic Opioid Drug" as to 150,000 options.
  • [F2]See Remarks.
  • [F3]100,000 of the options vested on September 2, 2006 and 100,000 of the options vested on September 2, 2007.
  • [F4]Represents a previously granted option to purchase 300,000 shares of the Registrant's Common Stock of which the Reporting person waived and released any and all rights to receive or exercise such options as to 75,000 shares of Common Stock. The remaining 225,000 shares of Common Stock vested on September 2, 2005.

Documents

1 file

Issuer

ELITE PHARMACEUTICALS INC /DE/

CIK 0001053369

Entity typeoperating
IncorporatedNJ

Related Parties

1
  • filerCIK 0001053369

Filing Metadata

Form type
4
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 9:20 PM ET
Size
18.8 KB